Posted on 9/14/17
Teva: Avoid
Source: TradingviewInvestment ThesisTeva Pharmaceutical (TEVA) recently announced that it has entered into a definitive agreement to sell its Paragard contraceptive device to CooperSurgical for $1.1 billion . . .
Source: TradingviewInvestment ThesisTeva Pharmaceutical (TEVA) recently announced that it has entered into a definitive agreement to sell its Paragard contraceptive device to CooperSurgical for $1.1 billion . . .